A detailed history of Cibc Private Wealth Group, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 172 shares of ATRC stock, worth $6,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares
172
Previous 128 34.38%
Holding current value
$6,470
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$19.86 - $29.09 $873 - $1,279
44 Added 34.38%
172 $3,000
Q1 2024

May 10, 2024

BUY
$28.21 - $37.78 $3,610 - $4,835
128 New
128 $3,000
Q3 2018

Nov 14, 2018

SELL
$27.62 - $35.58 $12,567 - $16,188
-455 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$17.69 - $23.44 $8,048 - $10,665
455
455 $8,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.75B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.